1. Zmanovskaya V.A., Levitina E.V., Popkov D.A., Butorina M.N., Pavlova O.L. Long-term use of botulinum toxin type A: Dysport® in the comprehensive rehabilitation of children with spastic forms of paralysis. Zhurnal Nevrologii i Psichiatriy imeni S.S. Korsakova. 2014; 7: 33-6. (in Russian)
2. Kurenkov A.L., Bursagova B.I., Kuzenkova L.M., Petrova S.A. The use of botulinum toxin type A in spastic forms of cerebral palsy, effective pharmacotherapy. Pediatriya. 2013; 3: 14-20. (in Russian)
3. Eams N.W.A., Barker R., Gracham K. et al. The effect of botulinum toxin type A on gastrocnemius length: magnitude and duration of response. Dev. Med. Child Neurol. 1999; 41: 226–32.
4. Ugrekhelidze D.T. Yagudina R.I., Methodological aspects of conducting a pharmacoeconomic study of the treatment of spastic forms of cerebral palsy. Pharmacoeconomika. Teoriya i practika. 2017; 5 (2): 5-8. (in Russian)
5. Batysheva T.T., Guzeva V.I., Bykova O.V., Shioshvili V.A., Nogova E.V., Fleoris L.V. et al. Treatment and rehabilitation of children with spastic forms of cerebral palsy. Guidelines. Moscow; 2016; 26. (in Russian)